More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
A study led by Professor Ginestra Bianconi from Queen Mary University of London, in collaboration with international ...
Little is known about the associated brain activation during these sleep rhythms, and even less about their functional implications. In this study, we investigated the brain-wide activation underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback